Therefore, the binding between furin with pro-MT1-MMP or pro-VEGF-C or other tumor-associated enzyme precursors can be regulated by c-Src activity, thereby reducing or changing the expression of these enzymes in order to inhibit the development of gastric cancer invasion and metastasis. Here, SRC is linked to gastric cancer.